comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 21:05:06 - browse：4679

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： PBM executives asked to testify by House panel

WSS

Sanders adds drug shortage policies to pandemic preparedness bill

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

AltruBio raises $225 million to develop ulcerative colitis drug

Is it ever OK for doctors to lie to their patients?

A public scorecard can help hold safety

Startup Neumora takes a novel depression drug to Phase 3

knowledge

comprehensive

Wikipedia

Supreme Court strikes down use of affirmative action

STAT Virtual Event: The State of Biosimilars: What to Watch

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Lawmakers grill UnitedHealth CEO on Change cyberattack

Medicare details structure of new drug price negotiation program

PBM executives asked to testify by House panel

Cancer drug shortages should be causing more outrage

AltruBio raises $225 million to develop ulcerative colitis drug

As demand for Covid shots wanes, Moderna seeks its next success

In early work, researchers turn to CRISPR to treat Alzheimer's

explore

In early work, researchers turn to CRISPR to treat Alzheimer's

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Welsh Carson private equity firm escapes from FTC antitrust case

As digital health tech proliferates, a new institute aims to cut through hype

Welsh Carson private equity firm escapes from FTC antitrust case

Sepsis can kill a child within hours. Here's how hospitals are fighting back

hotspot

entertainment

explore

focus